JP2018516254A5 - - Google Patents

Download PDF

Info

Publication number
JP2018516254A5
JP2018516254A5 JP2017561653A JP2017561653A JP2018516254A5 JP 2018516254 A5 JP2018516254 A5 JP 2018516254A5 JP 2017561653 A JP2017561653 A JP 2017561653A JP 2017561653 A JP2017561653 A JP 2017561653A JP 2018516254 A5 JP2018516254 A5 JP 2018516254A5
Authority
JP
Japan
Prior art keywords
pyrimidin
amino
methanone
phenyl
benzonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017561653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018516254A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/052825 external-priority patent/WO2016193844A1/en
Publication of JP2018516254A publication Critical patent/JP2018516254A/ja
Publication of JP2018516254A5 publication Critical patent/JP2018516254A5/ja
Pending legal-status Critical Current

Links

JP2017561653A 2015-05-29 2016-05-16 バニン1酵素の阻害薬としての新規なヘテロ環化合物 Pending JP2018516254A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562167962P 2015-05-29 2015-05-29
US62/167,962 2015-05-29
US201562195005P 2015-07-21 2015-07-21
US62/195,005 2015-07-21
PCT/IB2016/052825 WO2016193844A1 (en) 2015-05-29 2016-05-16 Novel heterocyclic compounds as inhibitors of vanin-1 enzyme

Publications (2)

Publication Number Publication Date
JP2018516254A JP2018516254A (ja) 2018-06-21
JP2018516254A5 true JP2018516254A5 (enExample) 2019-05-23

Family

ID=56026933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017561653A Pending JP2018516254A (ja) 2015-05-29 2016-05-16 バニン1酵素の阻害薬としての新規なヘテロ環化合物

Country Status (5)

Country Link
US (2) US10308615B2 (enExample)
EP (1) EP3303303A1 (enExample)
JP (1) JP2018516254A (enExample)
CA (1) CA2987179C (enExample)
WO (1) WO2016193844A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201811161YA (en) * 2016-07-14 2019-01-30 Pfizer Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
KR101798840B1 (ko) 2017-05-17 2017-11-17 주식회사 레고켐 바이오사이언스 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물
US10961242B2 (en) 2017-05-17 2021-03-30 Legochem Biosciences, Inc. Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same
PL3638680T3 (pl) * 2017-06-12 2022-12-19 Boehringer Ingelheim International Gmbh Związki heteroaromatyczne jako inhibitory waniny
WO2018231702A1 (en) 2017-06-13 2018-12-20 The Regents Of The University Of California Methods of improving cell-based therapy
US10702488B2 (en) * 2017-12-19 2020-07-07 Theriac Biomedical Inc. PPAR-γ activators, HDAC inhibitors and their therapeutical usages
US11497723B1 (en) * 2017-12-19 2022-11-15 Tony Antakly PPAR-gamma activators, HDAC inhibitors and their therapeutical usages
WO2019133445A1 (en) * 2017-12-28 2019-07-04 Inception Ibd, Inc. Aminothiazoles as inhibitors of vanin-1
HUE061186T2 (hu) 2018-08-28 2023-06-28 Boehringer Ingelheim Int Heteroaromás vegyületek mint vanin-inhibitorok
WO2020102575A1 (en) * 2018-11-16 2020-05-22 Inception Ibd, Inc. Heterocyclic aminothiazoles and uses thereof
CA3116830A1 (en) * 2018-12-03 2020-06-11 Boehringer Ingelheim International Gmbh Heteroaromatic compounds as vanin inhibitors
CA3120037A1 (en) * 2018-12-03 2020-06-11 Boehringer Ingelheim International Gmbh Heteroaromatic compounds as vanin inhibitors
BR112021010690A2 (pt) 2018-12-03 2021-08-24 Boehringer Ingelheim International Gmbh Compostos heteroaromáticos como inibidores de vanina
EP4054556A4 (en) * 2019-11-07 2023-11-29 Increvet, Inc. SODIUM-GLUCOSE TRANSPORTER INHIBITORS FOR THE MANAGEMENT OF CHRONIC KIDNEY FAILURE, HYPERTENSION AND HEART FAILURE IN PETS
WO2022081716A1 (en) * 2020-10-13 2022-04-21 Accubit LLC - Biotechnology Methods of treating iga nephropathy with thiol-containing molecules
WO2022127909A1 (zh) * 2020-12-17 2022-06-23 上海美悦生物科技发展有限公司 一种嘧啶甲酰胺类化合物及其应用
CN120247898A (zh) * 2025-03-31 2025-07-04 大连医科大学附属第二医院 一种噻吩甲酰胺类化合物及其用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
IL140622A0 (en) 1998-07-06 2002-02-10 Bristol Myers Squibb Co Biphenyl sufonamide derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
NZ534582A (en) 2002-02-27 2006-03-31 Pfizer Prod Inc ACC inhibitors
PT1753748E (pt) 2004-05-12 2009-08-28 Pfizer Prod Inc Derivados de prolina e a sua utilização como inibidores de dipeptidil peptidase iv
ES2487967T3 (es) 2006-04-20 2014-08-25 Pfizer Products Inc. Compuestos amido heterocíclicos condensados con fenilo para la prevención y el tratamiento de enfermedades mediadas por la glucoquinasa
WO2008063888A2 (en) * 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
CN101541809A (zh) 2006-11-29 2009-09-23 辉瑞产品公司 螺环酮乙酰基-CoA羧化酶抑制剂
US20090036425A1 (en) 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
WO2009143018A2 (en) 2008-05-19 2009-11-26 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
CA2724774C (en) 2008-05-28 2013-06-25 Pfizer Inc. Pyrazolospiroketone acetyl-coa carboxylase inhibitors
CA2724603A1 (en) 2008-05-28 2009-12-03 Pfizer Inc. Pyrazolospiroketone acetyl-coa carboxylase inhibitors
EP2318370A1 (en) 2008-07-29 2011-05-11 Pfizer Inc. Fluorinated heteroaryls
CN102149717B (zh) 2008-08-28 2014-05-14 辉瑞大药厂 二氧杂-双环[3.2.1]辛烷-2,3,4-三醇衍生物
TW201038580A (en) 2009-02-02 2010-11-01 Pfizer 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
AU2010222589B2 (en) 2009-03-11 2012-08-16 Pfizer Inc. Benzofuranyl derivatives used as glucokinase inhibitors
WO2010103438A1 (en) 2009-03-11 2010-09-16 Pfizer Inc. Substituted indazole amides and their use as glucokinase activators
JP2012520868A (ja) 2009-03-20 2012-09-10 ファイザー・インク 3−オキサ−7−アザビシクロ[3.3.1]ノナン
WO2010128425A1 (en) 2009-05-08 2010-11-11 Pfizer Inc. Gpr 119 modulators
JP2012526096A (ja) 2009-05-08 2012-10-25 ファイザー・インク Gpr119調節因子
JP2012528847A (ja) 2009-06-05 2012-11-15 ファイザー・インク Gpr119調節因子としてのl−(ピペリジン−4−イル)−ピラゾール誘導体
WO2011005611A1 (en) 2009-07-09 2011-01-13 Merck Sharp & Dohme Corp. Neuromedin u receptor agonists and uses thereof
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
ES2653966T3 (es) 2010-04-27 2018-02-09 Mitsubishi Tanabe Pharma Corporation Nuevo derivado de amida y su uso como medicina
CA2836474A1 (en) 2011-05-17 2012-11-22 Plexxikon Inc. Kinase modulation and indications therefor
WO2013019621A1 (en) 2011-07-29 2013-02-07 Tempero Pharmaceuticals, Inc. Compounds and methods
WO2013151938A1 (en) 2012-04-02 2013-10-10 Cytokinetics, Inc. Methods for improving diaphragm function
AU2013324696B2 (en) 2012-09-25 2017-09-14 Merck Patent Gmbh Alpha hydroxy amides

Similar Documents

Publication Publication Date Title
JP2018516254A5 (enExample)
HRP20220096T1 (hr) Inhibitori lizin specifične demetilaze-1
RU2008141509A (ru) Mglur5 модуляторы 1
RU2452738C2 (ru) Соединения, модулирующие активность c-fms и/или c-kit, и их применения
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
JP2007501189A5 (enExample)
RU2009125620A (ru) Органические соединения
JP2009519967A5 (enExample)
CN115515947A (zh) Shp2抑制剂及其组合物和应用
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
JP2010514788A5 (enExample)
RU2015154987A (ru) Гетероциклические производные
JP2007519735A5 (enExample)
JP2006500348A5 (enExample)
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2005516934A5 (enExample)
RU2014153626A (ru) Пиридиноновые и пиридазиноновые производные
JP2016519096A5 (enExample)
JP2020526547A5 (enExample)
HRP20141190T1 (hr) Disupstituirani derivati piridina kao antikancerogena sredstva
RU2015143517A (ru) Пиразолсодержащие соединения и их применения
JP2008507564A5 (enExample)
JP2005511543A5 (enExample)
JP2013527173A5 (enExample)